Literature DB >> 34984108

Primary Cardiac Lymphoma: Three Case Reports and a Review of the Literature.

Clifford Michael Csizmar1, Zohar Sachs2, Zuzan Cayci3, Lihong Bu4, Michael Andrew Linden4.   

Abstract

Primary cardiac lymphoma (PCL) is a rare entity that comprises only 1-2% of all cardiac tumors. Due to their scarcity and variable clinical presentation, early diagnosis is challenging. In this series, three cases of PCL from a single institution are described, which highlight the spectrum of presenting features and emphasize common principles. In the first case, a 73-year-old male who presented with dyspnea was found to have a 12.1 cm mass in the right ventricle. Biopsy via cardiac catheterization revealed diffuse large B cell lymphoma (DLBCL). He was treated with chemoimmunotherapy and survived for two months. The second case describes a 55-year-old female who presented with chest pain. Imaging revealed a 3.1 cm right atrial mass and bilateral pleural effusions, with cytology from the latter demonstrating DLBCL. She was lost to follow up after three cycles of chemoimmunotherapy. In the last case, an 80-year-old female presented with weakness. A 4.0 cm mass was discovered in the right atrium and the patient expired shortly after admission. Autopsy confirmed the diagnosis of DLBCL. These case summaries are followed by a review of the clinical presentation, diagnostic approach, and treatment outcomes of PCL.

Entities:  

Keywords:  Primary cardiac lymphoma; cardiac tumors; diffuse large B cell lymphoma

Year:  2021        PMID: 34984108      PMCID: PMC8722531          DOI: 10.4236/ojbd.2021.114012

Source DB:  PubMed          Journal:  Open J Blood Dis        ISSN: 2164-3199


  32 in total

Review 1.  Pathological findings of HIV-associated cardiovascular disease.

Authors:  G d'Amati; C R di Gioia; P Gallo
Journal:  Ann N Y Acad Sci       Date:  2001-11       Impact factor: 5.691

2.  Primary cardiac lymphoma: B- and T-cell cases at a specialist UK centre.

Authors:  J Patel; L Melly; M N Sheppard
Journal:  Ann Oncol       Date:  2009-10-21       Impact factor: 32.976

3.  EBV+ diffuse large B-cell lymphoma arising within atrial myxoma in Chinese immunocompetent patient.

Authors:  Xiaoyan Liu; Pu Liu; Jun Li
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Risk factors for QTc-prolongation: systematic review of the evidence.

Authors:  Eline Vandael; Bert Vandenberk; Joris Vandenberghe; Rik Willems; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2016-12-23

Review 5.  Cardiac myxomas.

Authors:  K Reynen
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Primary cardiac MYC/BCL6 double hit non-Hodgkin lymphoma.

Authors:  Ombretta Annibali; Antonio Nenna; Raffaele Barbato; Massimo Chello; Pietro Sedati; Antonella Bianchi; Giuseppe Deda; Giuseppe Avvisati
Journal:  J Cardiol Cases       Date:  2017-12-08

7.  The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.

Authors:  Rie Hyo; Naoto Tomita; Kengo Takeuchi; Tomohiro Aoshima; Atsuko Fujita; Hideyuki Kuwabara; Chizuko Hashimoto; Sachiya Takemura; Jun Taguchi; Rika Sakai; Hiroyuki Fujita; Shin Fujisawa; Koji Ogawa; Shigeki Motomura; Ritsuro Suzuki; Yoshiaki Ishigatsubo
Journal:  Hematol Oncol       Date:  2010-03       Impact factor: 5.271

Review 8.  Primary cardiac lymphoma: case report and brief review of the literature.

Authors:  Loizos Antoniades; Christos Eftychiou; Petros M Petrou; Athanasios Bagatzounis; Michalis Minas
Journal:  Echocardiography       Date:  2008-10-08       Impact factor: 1.724

Review 9.  Primary cardiac lymphoma: two cases and a review of literature.

Authors:  Karolis Jonavicius; Kestutis Salcius; Raimundas Meskauskas; Nomeda Valeviciene; Virgilijus Tarutis; Vytautas Sirvydis
Journal:  J Cardiothorac Surg       Date:  2015-10-30       Impact factor: 1.637

10.  Rare Intracardiac Tumor: Primary Cardiac Lymphoma Presenting as Atypical Angina.

Authors:  Karthigesu Aimanan; K Saravana Kumar; M N Mohd Arif; Md Noor Zuraini; Md Jamil Ramdzan; L Hamdan
Journal:  Case Rep Med       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.